CasCure Therapeutics

South Korea
Ulsan, Ulsan, South Korea

Company profile

CasCure Therapeutics company profile

CasCure Therapeutics develops personalized chemotherapy technology. The company uses artificial intelligence algorithms and deep learning technology for pipeline devices, such as Platform C for developing precision cancer medicines and Platform H for anti-cancer drugs, to provide medical professionals with a solution to cure cancer.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Founded
2020-01-01, Year

Headquarters

Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2022-01-01
Last equity funding
Seed
Investors
1

Founders and investors

Investors

Dayli Partners